Cargando…

Alterations in PGC1α expression levels are involved in colorectal cancer risk: a qualitative systematic review

BACKGROUND: Colorectal cancer (CRC) is a major global public health problem and the second leading cause of cancer-related death. Mitochondrial dysfunction has long been suspected to be involved in this type of tumorigenesis, as supported by an accumulating body of research evidence. However, little...

Descripción completa

Detalles Bibliográficos
Autores principales: Alonso-Molero, Jéssica, González-Donquiles, Carmen, Fernández-Villa, Tania, de Souza-Teixeira, Fernanda, Vilorio-Marqués, Laura, Molina, Antonio J., Martín, Vicente
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679491/
https://www.ncbi.nlm.nih.gov/pubmed/29121859
http://dx.doi.org/10.1186/s12885-017-3725-3
_version_ 1783277583386804224
author Alonso-Molero, Jéssica
González-Donquiles, Carmen
Fernández-Villa, Tania
de Souza-Teixeira, Fernanda
Vilorio-Marqués, Laura
Molina, Antonio J.
Martín, Vicente
author_facet Alonso-Molero, Jéssica
González-Donquiles, Carmen
Fernández-Villa, Tania
de Souza-Teixeira, Fernanda
Vilorio-Marqués, Laura
Molina, Antonio J.
Martín, Vicente
author_sort Alonso-Molero, Jéssica
collection PubMed
description BACKGROUND: Colorectal cancer (CRC) is a major global public health problem and the second leading cause of cancer-related death. Mitochondrial dysfunction has long been suspected to be involved in this type of tumorigenesis, as supported by an accumulating body of research evidence. However, little is known about how mitochondrial alterations contribute to tumorigenesis. Mitochondrial biogenesis is a fundamental cellular process required to maintain functional mitochondria and as an adaptive mechanism in response to changing energy requirements. Mitochondrial biogenesis is regulated by peroxisome proliferator-activated receptor gamma coactivator 1-α (PPARGC1A or PGC1α). In this paper, we report a systematic review to summarize current evidence on the role of PGC1α in the initiation and progression of CRC. The aim is to provide a basis for more comprehensive research. METHODS: The literature search, data extraction and quality assessment were performed according to the document Guidance on the Conduct of Narrative Synthesis in Systematic Reviews and the PRISMA declaration. RESULTS: The studies included in this review aimed to evaluate whether increased or decreased PGC1α expression affects the development of CRC. Each article proposes a possible molecular mechanism of action and we create two concept maps. CONCLUSION: Our systematic review indicates that altered expression of PGC1α modifies CRC risk. Most studies showed that overexpression of this gene increases CRC risk, while some studies indicated that lower than normal expression levels could increase CRC risk. Thus, various authors propose PGC1α as a good candidate molecular target for cancer therapy. Reducing expression of this gene could help to reduce risk or progression of CRC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-017-3725-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5679491
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56794912017-11-17 Alterations in PGC1α expression levels are involved in colorectal cancer risk: a qualitative systematic review Alonso-Molero, Jéssica González-Donquiles, Carmen Fernández-Villa, Tania de Souza-Teixeira, Fernanda Vilorio-Marqués, Laura Molina, Antonio J. Martín, Vicente BMC Cancer Research Article BACKGROUND: Colorectal cancer (CRC) is a major global public health problem and the second leading cause of cancer-related death. Mitochondrial dysfunction has long been suspected to be involved in this type of tumorigenesis, as supported by an accumulating body of research evidence. However, little is known about how mitochondrial alterations contribute to tumorigenesis. Mitochondrial biogenesis is a fundamental cellular process required to maintain functional mitochondria and as an adaptive mechanism in response to changing energy requirements. Mitochondrial biogenesis is regulated by peroxisome proliferator-activated receptor gamma coactivator 1-α (PPARGC1A or PGC1α). In this paper, we report a systematic review to summarize current evidence on the role of PGC1α in the initiation and progression of CRC. The aim is to provide a basis for more comprehensive research. METHODS: The literature search, data extraction and quality assessment were performed according to the document Guidance on the Conduct of Narrative Synthesis in Systematic Reviews and the PRISMA declaration. RESULTS: The studies included in this review aimed to evaluate whether increased or decreased PGC1α expression affects the development of CRC. Each article proposes a possible molecular mechanism of action and we create two concept maps. CONCLUSION: Our systematic review indicates that altered expression of PGC1α modifies CRC risk. Most studies showed that overexpression of this gene increases CRC risk, while some studies indicated that lower than normal expression levels could increase CRC risk. Thus, various authors propose PGC1α as a good candidate molecular target for cancer therapy. Reducing expression of this gene could help to reduce risk or progression of CRC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-017-3725-3) contains supplementary material, which is available to authorized users. BioMed Central 2017-11-09 /pmc/articles/PMC5679491/ /pubmed/29121859 http://dx.doi.org/10.1186/s12885-017-3725-3 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Alonso-Molero, Jéssica
González-Donquiles, Carmen
Fernández-Villa, Tania
de Souza-Teixeira, Fernanda
Vilorio-Marqués, Laura
Molina, Antonio J.
Martín, Vicente
Alterations in PGC1α expression levels are involved in colorectal cancer risk: a qualitative systematic review
title Alterations in PGC1α expression levels are involved in colorectal cancer risk: a qualitative systematic review
title_full Alterations in PGC1α expression levels are involved in colorectal cancer risk: a qualitative systematic review
title_fullStr Alterations in PGC1α expression levels are involved in colorectal cancer risk: a qualitative systematic review
title_full_unstemmed Alterations in PGC1α expression levels are involved in colorectal cancer risk: a qualitative systematic review
title_short Alterations in PGC1α expression levels are involved in colorectal cancer risk: a qualitative systematic review
title_sort alterations in pgc1α expression levels are involved in colorectal cancer risk: a qualitative systematic review
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679491/
https://www.ncbi.nlm.nih.gov/pubmed/29121859
http://dx.doi.org/10.1186/s12885-017-3725-3
work_keys_str_mv AT alonsomolerojessica alterationsinpgc1aexpressionlevelsareinvolvedincolorectalcancerriskaqualitativesystematicreview
AT gonzalezdonquilescarmen alterationsinpgc1aexpressionlevelsareinvolvedincolorectalcancerriskaqualitativesystematicreview
AT fernandezvillatania alterationsinpgc1aexpressionlevelsareinvolvedincolorectalcancerriskaqualitativesystematicreview
AT desouzateixeirafernanda alterationsinpgc1aexpressionlevelsareinvolvedincolorectalcancerriskaqualitativesystematicreview
AT viloriomarqueslaura alterationsinpgc1aexpressionlevelsareinvolvedincolorectalcancerriskaqualitativesystematicreview
AT molinaantonioj alterationsinpgc1aexpressionlevelsareinvolvedincolorectalcancerriskaqualitativesystematicreview
AT martinvicente alterationsinpgc1aexpressionlevelsareinvolvedincolorectalcancerriskaqualitativesystematicreview